TP53 and non-Hodgkin lymphoma: Compared with the TP53 Arg/Arg genotype, a significantly increased risk of NHL was associated with TP53 Arg/Pro and Pro/Pro genotypes both among males (OR = 1.72, 95% CI = 1.08–2.73, P = 0.023), and among females (OR = 2.16, 95% CI = 1.13–4.10, P = 0.019).